3
Announcements
Trials
Browse
Landscape
Status
Available
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
90
Observational
9
Expanded_access
2
Sponsor
Cancer Type
Myeloid
2
Sarcoma
1
Plasma cell
1
Lymphoid
1
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Neoplasms
11
Multiple Myeloma
10
Recurrence
9
Pancreatic Neoplasms
8
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Melanoma
6
Sarcoma
5
Ovarian Neoplasms
5
Leukemia, Myeloid, Acute
5
Hematologic Neoplasms
4
Glioblastoma
4
Colorectal Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
3
Osteosarcoma
3
Non-Muscle Invasive Bladder Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Myelodysplastic Syndromes
3
Lymphoma, Large B-Cell, Diffuse
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Squamous Cell
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Interventions
selinexor
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Expanded_access
×
Primary Myelofibrosis
×
1 year
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available
NCT04745637
2025-11-18
Managed Access Programs for INC424, Ruxolitinib
Novartis
Available